Nvidia: Trading At A Rare Discount Just As Its Next AI Supercycle Kicks Off

Nvidia is benefiting from a severe GPU shortage that is strengthening pricing power and improving demand visibility, while also supporting acceleration of its annual data center product cycle. Foxconn's March 2026 revenue spike, tied to new product launches, suggests Nvidia's Vera Rubin ramp is progressing on schedule. A key offset is rising competition in China, where Huawei and Alibaba now control 41% of the AI accelerator market and are eroding Nvidia's share.

Analysis

The near-term setup still favors NVDA because scarcity does more than lift ASPs: it reduces customer bargaining power and shortens sales cycles, which tightens revenue visibility into the next two product turns. The more important second-order effect is that a clean ramp signal at the next platform should pull forward capex commitments from hyperscalers that have been waiting for proof-of-supply, potentially steepening orders into the next 2-3 quarters rather than just preserving current demand.

The competitive loss is not just share leakage to Chinese silicon, but a gradual erosion of NVDA’s default status in local inference workloads. Once a domestic stack gets to roughly 40% share, the adoption curve can become self-reinforcing through software localization, procurement policy, and system integration, even if raw performance still trails. That means BABA’s AI exposure should be treated less as a single-chip winner and more as an enabler of a national ecosystem that can capture workload share at the margin for years, especially in sovereign and regulated deployments.

The market is likely underpricing the option value of the next-gen ramp while overestimating the immediacy of the China threat. China can pressure the low-to-mid end first; it is much harder to displace NVDA in frontier training and the highest-value cluster budgets, so the share loss path is probably gradual rather than cliff-like. The real risk to the bullish NVDA view is not competition alone, but any evidence that the new platform ramp is supply-constrained or slips by even one quarter, because that would convert scarcity from a pricing tailwind into a shipment ceiling.

Key Decisions for Investors

• Add to NVDA on any post-print weakness over the next 1-4 weeks; the risk/reward remains favorable as long as next-platform channel checks continue to confirm on-schedule ramp and no material delivery slippage appears.
• Use a call spread in NVDA for the next 3-6 months rather than outright stock if you want upside exposure with defined risk; the thesis is more about sustained multiple support from visibility than a single-quarter earnings beat.
• Pair trade: long NVDA / short BABA on a 2-3 month horizon. The spread benefits from continued AI capex concentration at the top end while allowing for gradual China-share gains that should matter more to BABA’s narrative than to NVDA’s global earnings power.
• For more tactical downside protection, buy NVDA puts around the first major product-ramp milestone if channel inventory or lead times start normalizing faster than expected; that would be the earliest sign the scarcity premium is fading.
• If you want to express the China ecosystem thesis, treat BABA as a longer-dated, lower-conviction call option on domestic AI stack adoption, but size it smaller than the NVDA long because monetization and margins will lag hardware-share gains.